Stabilization of human urine doping control samples: III. Recombinant human erythropoietin

Tsivou, M; Dimopoulou, H; Leontiou, I; Georgakopoulos, D; Koupparis, M; Atta-Politou, J; Georgakopoulos, C

dc.contributor.author	Tsivou, M	en
dc.contributor.author	Dimopoulou, H	en
dc.contributor.author	Leontiou, I	en
dc.contributor.author	Georgakopoulos, D	en
dc.contributor.author	Koupparis, M	en
dc.contributor.author	Atta-Politou, J	en
dc.contributor.author	Georgakopoulos, C	en
dc.date.accessioned	2014-03-01T01:59:33Z
dc.date.available	2014-03-01T01:59:33Z
dc.date.issued	2010	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/28962
dc.subject	Erythropoietin	en
dc.subject	Proteolytic Enzyme	en
dc.subject	Recombinant Human Erythropoietin	en
dc.subject	World Anti Doping Agency	en
dc.title	Stabilization of human urine doping control samples: III. Recombinant human erythropoietin	en
heal.type	journalArticle	en
heal.identifier.primary	10.1016/j.cca.2009.11.029	en
heal.identifier.secondary	http://dx.doi.org/10.1016/j.cca.2009.11.029	en
heal.publicationDate	2010	en
heal.abstract	BackgroundThe tampering of athlete's urine samples by the addition of proteolytic enzymes during the doping control sampling procedure was reported recently. The aim of the current study, funded by the World Anti-Doping Agency (WADA), was the application of a stabilization mixture in urine samples to chemically inactivate proteolytic enzymes and improve the electrophoteric signal of erythropoietin (EPO) in human urine.	en
heal.journalName	Clinica Chimica Acta	en
dc.identifier.doi	10.1016/j.cca.2009.11.029	en